Your browser doesn't support javascript.
The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA.
Pritchard-Jones, Kathy; de C V Abib, Simone; Esiashvili, Natia; Kaspers, Gertjan J L; Rosser, Jon; Van Doorninck, John A; Braganca, João M L; Hoffman, Ruth I; Rodriguez-Galindo, Carlos; Adams, Cary; Connor, Stephen R; Abdelhafeez, Abdelhafeez H; Bouffet, Eric; Howard, Scott C; Challinor, Julia M; Hessissen, Laila; Dalvi, Rashmi B; Kearns, Pamela; Chantada, Guillermo L; Frazier, Lindsay A; Sullivan, Michael J; Schulte, Fiona S M; Morrissey, Lisa K; Kozhaeva, Olga; Luna-Fineman, Sandra; Khan, Muhammad S.
  • Pritchard-Jones K; UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1E, United Kingdom.
  • de C V Abib S; International Society of Paediatric Oncology (SIOP), Industriestrasse 25, 6312 Steinhausen, Switzerland.
  • Esiashvili N; Division of Pediatric Surgery, Pediatric Oncology Institute (GRAACC), Federal University of São Paulo, Rua Pedro de Toledo, 572, 04039-001 São Paulo, Brazil.
  • Kaspers GJL; International Society of Paediatric Surgical Oncology (IPSO), Tienrayseweg 10, 5961NL Horst, The Netherlands.
  • Rosser J; Department of Radiation Oncology, Winship Cancer Institute at Emory University, 1365 Clifton Road, NE, Atlanta, GA 30322, USA.
  • Van Doorninck JA; Paediatric Radiation Oncology Society (PROS), 28 rue Laennec, F-69373 Lyon, Cedex 08, France.
  • Braganca JML; Academy and Outreach, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, NL-3584 CS Utrecht, The Netherlands.
  • Hoffman RI; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1118, 1081 HV Amsterdam, The Netherlands.
  • Rodriguez-Galindo C; World Child Cancer (WCC), The Netherlands, P.O. Box 113, 3720 AC Bilthoven, The Netherlands.
  • Adams C; World Child Cancer (WCC) UK, 9 Maltings Place, London SE1 3JB, UK.
  • Connor SR; Department of Pediatrics, Division of Pediatric Hematology/Oncology, Rocky Mountain Hospital for Children, 2055 High Street, #340, Denver, CO 80211, USA.
  • Abdelhafeez AH; World Child Cancer (WCC) USA, 1301 Arapahoe St Suite 105, Golden, CO 80401, USA.
  • Bouffet E; Childhood Cancer International (CCI), Kraijenhoffstraat 137A, 1018RG Amsterdam, The Netherlands.
  • Howard SC; Childhood Cancer International (CCI), Kraijenhoffstraat 137A, 1018RG Amsterdam, The Netherlands.
  • Challinor JM; Department of Global Medicine, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
  • Hessissen L; Union for International Cancer Control (UICC), 31-33 Avenue Giuseppe Motta, 1202 Geneva, Switzerland.
  • Dalvi RB; Worldwide Hospice Palliative Care Alliance (WHPCA), 10990 Rice Field Pl, Fairfax Station, VA 22039, USA.
  • Kearns P; International Society of Paediatric Surgical Oncology (IPSO), Tienrayseweg 10, 5961NL Horst, The Netherlands.
  • Chantada GL; Department of Surgery, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
  • Frazier LA; International Society of Paediatric Oncology (SIOP), Industriestrasse 25, 6312 Steinhausen, Switzerland.
  • Sullivan MJ; Division of Haematology/Oncology, University of Toronto, The Hospital for Sick Children, 555 University Ave, M5G 1X8, Toronto, Canada.
  • Schulte FSM; International Society of Paediatric Oncology (SIOP), Industriestrasse 25, 6312 Steinhausen, Switzerland.
  • Morrissey LK; Department of Acute and Tertiary Care, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
  • Kozhaeva O; International Society of Paediatric Oncology (SIOP), Industriestrasse 25, 6312 Steinhausen, Switzerland.
  • Luna-Fineman S; School of Nursing, University of California San Francisco, 36 Rockview Dr., Santa Cruz, CA 95062, USA.
  • Khan MS; International Society of Paediatric Oncology (SIOP), Industriestrasse 25, 6312 Steinhausen, Switzerland.
Ecancermedicalscience ; 15: 1187, 2021.
Article in English | MEDLINE | ID: covidwho-1125655
ABSTRACT
The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive for the care of patients with life-threatening noncommunicable diseases (NCDs) such as the treatment of children and young people with cancer. The reduction in child mortality from preventable causes over the last 50 years has seen childhood cancer emerge as a major unmet health care need. Whilst survival rates of 85% have been achieved in high income countries, this has not yet been translated into similar outcomes for children with cancer in resource-limited settings where survival averages 30%. Launched in 2018, by the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC) is a pivotal effort by the international community to achieve at least 60% survival for children with cancer by 2030. The WHO GICC is already making an impact in many countries but the disruption of cancer care during the COVID-19 pandemic threatens to set back this global effort to improve the outcome for children with cancer, wherever they may live. As representatives of the global community committed to fostering the goals of the GICC, we applaud the WHO response to the COVID-19 pandemic, in particular we support the WHO's call to ensure the needs of patients with life threatening NCDs including cancer are not compromised during the pandemic. Here, as collaborative partners in the GICC, we highlight specific areas of focus that need to be addressed to ensure the immediate care of children and adolescents with cancer is not disrupted during the pandemic; and measures to sustain the development of cancer care so the long-term goals of the GICC are not lost during this global health crisis.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Ecancermedicalscience Year: 2021 Document Type: Article Affiliation country: Ecancer.2021.1187

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Ecancermedicalscience Year: 2021 Document Type: Article Affiliation country: Ecancer.2021.1187